1. Step 9
1.1. Review session 2
1.2. mechanism flow chart
1.2.1. idiopathic cause
1.2.2. age and gender
1.2.3. IgG , C3 deposition in basment membrane
1.2.4. symptoms of uremia --> lethargy
1.3. 20 minutes
2. Step 10
2.1. Management
2.1.1. goals of management
2.1.1.1. preservation of renal function
2.1.1.2. resolving nephrotic symptoms
2.1.1.3. preventing further complication
2.1.2. pharma
2.1.2.1. immune supressive
2.1.2.1.1. cyclophsophmide
2.1.2.1.2. cyclosporine A
2.1.2.1.3. monocolonal AB
2.1.2.1.4. catogorize patient on low, moderate and high risk
2.1.2.1.5. alternating month to month treatment based on guidline
2.1.2.1.6. indication
2.1.2.2. non-immune supressive
2.1.2.2.1. ACE inhibitors , ARB
2.1.2.2.2. Diuretics
2.1.2.2.3. lipid lowering agent
2.1.2.2.4. anticoagulant
2.1.3. non-pharma
2.1.3.1. surgical
2.1.3.1.1. transplantation
2.1.3.2. diet
2.1.3.2.1. low salt ,low protein
2.1.3.2.2. Vit D
2.1.3.3. physical activity
2.1.3.4. dialysis
2.1.3.4.1. haemodialysis
2.1.3.4.2. peritoneal dialysis
2.2. Prevention
2.2.1. secondary
2.2.1.1. mercury
2.2.1.2. early detection
2.2.2. teritry
2.2.2.1. lifestyle
2.2.2.1.1. qazqazqaz